These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2991619)

  • 1. Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination.
    Dienstag JL; Werner BG; McLane MF; Snydman DR; Grady GF; Craven DE; Crumpacker CS; Polk BF; Platt R; Allan J
    JAMA; 1985 Aug 23-30; 254(8):1064-6. PubMed ID: 2991619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of the hepatitis B vaccine. Inactivation of the AIDS virus during routine vaccine manufacture.
    Francis DP; Feorino PM; McDougal S; Warfield D; Getchell J; Cabradilla C; Tong M; Miller WJ; Schultz LD; Bailey FJ
    JAMA; 1986 Aug; 256(7):869-72. PubMed ID: 3016352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-III infection among health care workers. Association with needle-stick injuries.
    Weiss SH; Saxinger WC; Rechtman D; Grieco MH; Nadler J; Holman S; Ginzburg HM; Groopman JE; Goedert JJ; Markham PD
    JAMA; 1985 Oct; 254(15):2089-93. PubMed ID: 2995694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
    Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
    JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
    Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
    Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).
    Hirsch MS; Wormser GP; Schooley RT; Ho DD; Felsenstein D; Hopkins CC; Joline C; Duncanson F; Sarngadharan MG; Saxinger C
    N Engl J Med; 1985 Jan; 312(1):1-4. PubMed ID: 2981106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy.
    Mayer KH; Ayotte D; Groopman JE; Stoddard AM; Sarngadharan M; Gallo R
    Am J Med; 1986 Mar; 80(3):357-63. PubMed ID: 3006486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-III antibodies after hepatitis B vaccination.
    Kessler H; Chase R; Harris A; Jensen D; Levin S
    Lancet; 1985 Jun; 1(8444):1506-7. PubMed ID: 2861432
    [No Abstract]   [Full Text] [Related]  

  • 10. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virologic studies in a case of transfusion-associated AIDS.
    Groopman JE; Salahuddin SZ; Sarngadharan MG; Mullins JI; Sullivan JL; Mulder C; O'Hara CJ; Cheeseman SH; Haverkos H; Forgacs P
    N Engl J Med; 1984 Nov; 311(22):1419-22. PubMed ID: 6092957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
    Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
    N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of antibodies to LAV/HTLV-III in hepatitis B vaccine recipients.
    Papaevangelou G; Roumeliotou-Karayannis A; Kallinikos G; Politou K
    Eur J Epidemiol; 1985 Dec; 1(4):323-5. PubMed ID: 3855141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-III/LAV infection in hemodialysis patients.
    Peterman TA; Lang GR; Mikos NJ; Solomon SL; Schable CA; Feorino PM; Britz JA; Allen JR
    JAMA; 1986 May; 255(17):2324-6. PubMed ID: 3007792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
    Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
    Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
    Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
    N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune functions in homosexual men with antibodies to HTLV-III in Finland.
    Krohn K; Ranki A; Antonen J; Valle SL; Suni J; Vaheri A; Saxinger C; Gallo RC
    Clin Exp Immunol; 1985 Apr; 60(1):17-24. PubMed ID: 2988832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.